Factor VIII polypeptide
US7041635B2 · kind B2 · utility
81Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2003 |
| Grant date | May 9, 2006 |
| Priority date | — |
| Expiry date | Jan 10, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application discloses Factor VIII polypeptides comprising internal deletions of amino acids within the area of residues 741 to 1689, wherein the thrombin cleavage sites at about 741 and about 1689 are present, and a site at about 1648 is not present, as compared to human Factor VIII.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.